IGF-1 LR3 1mg

IGF-1 LR3 1 mg is supplied as a high-purity lyophilized peptide research compound intended exclusively for scientific and laboratory applications. For research use only — not for human or veterinary use.  

Product Overview

IGF-1 LR3 is a synthetic peptide research compound widely studied in controlled laboratory environments focused on growth factor signalling pathways, receptor interactions and cellular communication mechanisms. The compound is frequently investigated in experimental models examining peptide-mediated signalling networks and molecular regulatory systems. This preparation contains 1 mg of lyophilized IGF-1 LR3 supplied in a sealed research vial. Lyophilization helps preserve compound stability during storage and allows researchers to reconstitute the peptide for controlled laboratory experimentation. Due to its defined molecular structure, established analytical profile and extensive scientific literature, IGF-1 LR3 remains a recognised research compound within peptide-focused scientific investigations.  

Peptide Overview

IGF-1 LR3 is a modified analogue of insulin-like growth factor-1 designed for use in laboratory research. Researchers frequently investigate the compound in controlled experimental settings focused on receptor-mediated signalling systems and molecular communication pathways. The peptide has become widely recognised within scientific literature because of its defined amino acid sequence, reproducible analytical characteristics and suitability for controlled research applications. Its established role within peptide research has resulted in extensive investigation across numerous experimental models examining cellular signalling processes. IGF-1 LR3 continues to be utilised in scientific studies exploring peptide-receptor interactions and molecular regulatory mechanisms.  

Historical Background and Scientific Context

Scientific interest in growth factor peptides expanded considerably during the late twentieth century as researchers sought to better understand molecular signalling pathways involved in cellular communication. Advances in peptide synthesis and analytical testing technologies enabled the development of modified peptide analogues suitable for controlled laboratory investigation. IGF-1 LR3 subsequently emerged as a recognised compound within peptide research and continues to be referenced throughout scientific literature examining growth factor signalling systems. Its extensive research history has contributed to a substantial body of published scientific work focused on peptide-mediated molecular pathways.  

Mechanistic Focus in Research

Within controlled laboratory environments, IGF-1 LR3 is commonly studied in relation to receptor-mediated signalling pathways and intracellular communication systems. Research investigations frequently explore the compound in experimental models examining:

• Growth factor signalling pathways
• Peptide-receptor interaction dynamics
• Cellular communication mechanisms
• Intracellular signalling cascades
• Molecular regulatory pathways
• Comparative peptide investigations
• Cell signalling network analysis

These experimental approaches allow researchers to investigate complex biological processes associated with peptide-mediated signalling.  

Analytical Verification (COA)

Each batch of IGF-1 LR3 supplied by Grail Formula undergoes independent third-party laboratory verification to confirm peptide identity, assay content, purity and microbiological safety. Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic, spectrometric and mass spectrometry techniques. Batch: GF-IGFLR3-B241

• Assay Content: 1.096 mg
• Purity: 99.2 percent
• Identification by Retention Time: 0.996
• Identification by FTIR Spectrum: 989
• Molecular Ion Mass Identification: 9111 Da
• Bacterial Endotoxins: 0.012 EU/mg
• Total Aerobic Microbial Count: Not detected
• Total Yeast and Mold Count: Not detected

Independent elemental impurity screening confirmed no detectable arsenic, cadmium, mercury, lead, nickel, vanadium or cobalt. These analytical procedures provide confirmation of identity, purity, traceability and batch consistency for laboratory research applications.  

Research Applications

In controlled laboratory environments, IGF-1 LR3 may be utilised in experimental models designed to investigate growth factor signalling systems and peptide-mediated molecular pathways. Examples of research applications include:

• Growth factor signalling research
• Receptor interaction analysis
• Cellular communication studies
• Molecular pathway investigations
• Comparative peptide research
• Signal transduction modelling
• Controlled in vitro peptide studies

These applications are intended exclusively for scientific investigation and laboratory experimentation.  

Grail Formula Quality

Every Grail Formula research compound is supported by extensive independent analytical verification and full batch traceability. Each batch undergoes testing for:

• Peptide identity confirmation
• Assay content verification
• Purity assessment
• Molecular mass verification
• Endotoxin analysis
• Microbial contamination screening
• Heavy metal screening
• Batch traceability

Independent testing helps ensure consistent laboratory-grade research material suitable for controlled scientific applications.  

When You Choose Grail Formula

When selecting Grail Formula, researchers gain access to independently verified research compounds supported by detailed Certificates of Analysis and transparent batch-specific testing. Our commitment to quality includes publication of purity data, assay verification, identity confirmation, endotoxin screening, microbial testing, elemental impurity analysis and molecular mass verification. Every batch is supported by a downloadable COA issued by Liquilabs s.r.o. Czechia, providing full traceability and independent laboratory verification.  

Research Use Limitation

• Used solely for laboratory and in vitro research
• Not approved for human consumption
• Not approved for veterinary use
• Not intended for diagnostic purposes
• Not intended for therapeutic applications
• Not permitted for clinical administration
• For research use only

• Independently analysed by Liquilabs s.r.o. Czechia
• 99.2 % purity confirmed by COA
• Assay content verified at 1.096 mg
• Molecular ion mass identified at 9111 Da
• Endotoxin level measured at 0.012 EU/mg
• No detectable heavy metals or microbial contamination
• IGF-1 LR3 peptide research compound
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.